Skip to content


Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy

Jhingan et al. examined the relationship between idiopathic macular telangiectasis type 2 and coexistent diabetic retinopathy and they found that 12.5% of eyes with idiopathic macular telangiectasis type 2 in diabetic patients had concomitant diabetic retinopathy. Authors suggest that concurrence of either conditions in same patient may not pose deleterious effect on diseases progression.

Upcoming congresses

New Content Item

Retina World Congress is a non-profit organization dedicated to uniting international professionals to foster dialogue and to generate consensus about retinal diseases, emerging technologies and treatments, best practices and clinical research. Retina World Congress’ inaugural meeting brought together 150 faculty and more than 1,000 attendees from 32 U.S. states, 74 countries and 39 retina societies from around the globe. We unite again March 21-24, 2019 in Fort Lauderdale, Florida to share research, innovations and ideas with a growing audience. The educational experience begins on Thursday morning with the inaugural RWC Unplugged, a half day dedicated to the most debated topics in all of retina. RWC Unplugged offers participants a unique opportunity to learn, share and discuss controversial topics in retina with a large group of industry experts and clinical leaders with no scripts or industry commercials. 

For more information or to register for Retina World Congress and RWC Unplugged visit


Most accessed articles RSS

View all articles


Jay S Duker, Tufts University School of Medicine, USA
Eduardo B Rodrigues, Federal University of São Paulo, Brazil

Associate Editors

Anat Loewenstein, Tel Aviv University, Israel
Andre V Gomes, University of Sao Paulo, Brazil
Baruch D Kuppermann, University of California, Irvine, USA
Carsten H Meyer, Pallas Kliniken, Switzerland
Quan D Nguyen, University of Nebraska Medical Center, USA
Mauro Goldbaum, University of Sao Paulo, Brazil
Michel E Farah, Federal University of São Paulo, Brazil
Raul NG Vianna, Federal Fluminense University, Brazil

See full Editorial Board

Sign up to receive article alerts

International Journal of Retina and Vitreous is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

Code of Conduct

International Journal of Retina and Vitreous is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE).

All articles published in International Journal of Retina and Vitreous are included in PubMed, PubMed Central and DOAJ (Directory of Open Access Journals).

Aims and scope

International Journal of Retina and Vitreous focuses on the ophthalmic subspecialty of vitreoretinal disorders. The journal presents original articles on new approaches to diagnosis, outcomes of clinical trials, innovations in pharmacological therapy and surgical techniques, as well as basic science advances that impact clinical practice. Topical areas include, but are not limited to:

  • Imaging of the retina, choroid and vitreous
  • Innovations in optical coherence tomography (OCT)
  • Small-gauge vitrectomy, retinal detachment, chromovitrectomy
  • Electroretinography (ERG), microperimetry, other functional tests
  • Intraocular tumors
  • Retinal pharmacotherapy & drug delivery
  • Diabetic retinopathy & other vascular diseases
  • Age-related macular degeneration (AMD) & other macular entities

We publish movies

Movies that illustrate the methods and/or results sections of your manuscript can be added as additional files. More info here.

Publication fees

The publication costs for International Journal of Retina and Vitreous are currently covered by the Brazilian Retina and Vitreous Society and therefore no fees for article processing will be charged to authors whose articles are accepted for publication in the journal. 

If you wish to make a presubmission enquiry about the suitability of your manuscript, please contact:


The official journal of the Brazilian Retina and Vitreous Society

International Journal of Retina and Vitreous is endorsed by the Pan American Society of Retina and Vitreous

2017 Journal Metrics

  • Speed
    44 days to first decision for reviewed manuscripts only
    36 days to first decision for all manuscripts 
    87 days from submission to acceptance
    14 days from acceptance to publication

    27 Altmetric Mentions